GUANGZHOU BAIYUNSHAN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 874 for the last quarter is 19.53 B HKD, and it's 0.36% higher compared to the previous quarter. The net income of Q3 24 is 663.13 M HKD.